TV-46046

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Contraception

Phase 1

A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046

CompletedNCT03700658

Teva Branded Pharmaceutical Products R&D, Inc.Contraception

Start: 2019-01-15End: 2020-10-02Updated: 2022-01-26

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

CompletedNCT04682353

Teva Branded Pharmaceutical Products R&D, Inc.Contraception

Start: 2020-12-14End: 2023-01-12Updated: 2024-02-26